1-9 of 9
Silvia Novello
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade

Annapaola Mariniello, Tahseen H. Nasti, Daniel Y. Chang, Masao Hashimoto, Sakshi Malik, Daniel T. McManus, Judong Lee, Donald J. McGuire, Maria A. Cardenas, Pablo Umana, Valeria Nicolini, Rustom Antia, Ananya Saha, Zachary Buchwald, Hayden Kissick, Ehsan Ghorani, Silvia Novello, Dario Sangiolo, Giorgio V. Scagliotti, Suresh S. Ramalingam, Rafi Ahmed
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF13.
https://doi.org/10.1158/1078-0432.CCR-23-1316
Published: 07 December 2023
View article titled, Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
Open the PDF for Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer

Dario P. Anobile, Iris C. Salaroglio, Fabrizio Tabbò, Sofia La Vecchia, Muhlis Akman, Francesca Napoli, Maristella Bungaro, Federica Benso, Elisabetta Aldieri, Paolo Bironzo, Joanna Kopecka, Francesco Passiglia, Luisella Righi, Silvia Novello, Giorgio V. Scagliotti, Chiara Riganti
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (19): 3958–3973.
https://doi.org/10.1158/1078-0432.CCR-22-3949
Published: 02 October 2023
View article titled, Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
Open the PDF for Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells

Ramona Rotolo, Valeria Leuci, Chiara Donini, Federica Galvagno, Annamaria Massa, Maria Chiara De Santis, Serena Peirone, Giovanni Medico, Martina Sanlorenzo, Igor Vujic, Loretta Gammaitoni, Marco Basiricò, Luisella Righi, Chiara Riganti, Iris Chiara Salaroglio, Francesca Napoli, Fabrizio Tabbò, Annapaola Mariniello, Elisa Vigna, Chiara Modica, Lorenzo D’Ambrosio, Giovanni Grignani, Riccardo Taulli, Emilio Hirsch, Matteo Cereda, Massimo Aglietta, Giorgio Vittorio Scagliotti, Silvia Novello, Paolo Bironzo, Dario Sangiolo
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (3): 621–634.
https://doi.org/10.1158/1078-0432.CCR-22-0761
Published: 01 February 2023
View article titled, Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1<sup>+</sup> Chemoresistant Lung Cancer Cells
Open the PDF for Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1<sup>+</sup> Chemoresistant Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung

Valentina Monica, Giorgio V. Scagliotti, Paolo Ceppi, Luisella Righi, Alberto Cambieri, Marco Lo Iacono, Silvia Saviozzi, Marco Volante, Silvia Novello, Mauro Papotti
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7547–7552.
https://doi.org/10.1158/1078-0432.CCR-09-1641
Published: 14 December 2009
View article titled, Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung
Open the PDF for Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung in another window
Journal Articles

Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy

Paolo Ceppi, Silvia Novello, Alberto Cambieri, Marina Longo, Valentina Monica, Marco Lo Iacono, Matteo Giaj-Levra, Silvia Saviozzi, Marco Volante, Mauro Papotti, Giorgio Scagliotti
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 1039–1045.
https://doi.org/10.1158/1078-0432.CCR-08-1227
Published: 02 February 2009
View article titled, Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Open the PDF for Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy in another window
Journal Articles

Prospective Assessment of XPD Lys751Gln and XRCC1 Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer

Daniela F. Giachino, Paolo Ghio, Silvia Regazzoni, Giorgia Mandrile, Silvia Novello, Giovanni Selvaggi, Dario Gregori, Mario DeMarchi, Giorgio V. Scagliotti
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 2876–2881.
https://doi.org/10.1158/1078-0432.CCR-06-2543
Published: 15 May 2007
View article titled, Prospective Assessment of <em>XPD</em> Lys751Gln and <em>XRCC1</em> Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer
Open the PDF for Prospective Assessment of <em>XPD</em> Lys751Gln and <em>XRCC1</em> Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer in another window
Journal Articles

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Giorgio V. Scagliotti, Cornelius Kortsik, Graham G. Dark, Allan Price, Christian Manegold, Rafael Rosell, Mary O'Brien, Patrick M. Peterson, Daniel Castellano, Giovanni Selvaggi, Silvia Novello, Johannes Blatter, Louis Kayitalire, Lucio Crino, Luis Paz-Ares
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 690–696.
https://doi.org/10.1158/1078-0432.690.11.2
Published: 08 February 2005
View article titled, Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial
Open the PDF for Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial in another window
Journal Articles

Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer

Christian Monnerat, Thierry Le Chevalier, Karen Kelly, Coleman K. Obasaju, Julie Brahmer, Silvia Novello, Takashi Nakamura, Astra M. Liepa, Laurence Bozec, Paul A. Bunn, Jr, David S. Ettinger
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5439–5446.
https://doi.org/10.1158/1078-0432.CCR-04-0218
Published: 24 August 2004
View article titled, Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Open the PDF for Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer in another window
Journal Articles

The Biology of Epidermal Growth Factor Receptor in Lung Cancer

Giorgio V. Scagliotti, Giovanni Selvaggi, Silvia Novello, Fred R. Hirsch
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4227s–4232s.
https://doi.org/10.1158/1078-0432.CCR-040007
Published: 15 June 2004
View article titled, The Biology of Epidermal Growth Factor Receptor in Lung Cancer
Open the PDF for The Biology of Epidermal Growth Factor Receptor in Lung Cancer in another window